speb/financial-data huggingface dataset:
HCA income_statement (annual, 2022-12-31) — EBIT: 10321000000.00
HCA income_statement (annual, 2022-12-31) — EBITDA: 13290000000.00
HCA income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 45000000.00
HCA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -20000000.00
HCA cash_flow (annual, 2022-12-31) — End Cash Position: 908000000.00
HCA cash_flow (annual, 2022-12-31) — Financing Cash Flow: -5656000000.00
HCA cash_flow (annual, 2022-12-31) — Free Cash Flow: 4127000000.00
HCA cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -1301000000.00
HCA income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 1301000000.00
HCA income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 1301000000.00
HCA balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -490000000.00
HCA income_statement (annual, 2022-12-31) — General And Administrative Expense: 27685000000.00
HCA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 9653000000.00
HCA balance_sheet (annual, 2022-12-31) — Gross PPE: 56822000000.00
HCA income_statement (annual, 2022-12-31) — Gross Profit: 23177000000.00
HCA cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1175000000.00
HCA income_statement (annual, 2022-12-31) — Interest Expense: 1741000000.00
HCA income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1741000000.00
HCA cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1662000000.00
HCA balance_sheet (annual, 2022-12-31) — Interest Payable: 402000000.00
HCA balance_sheet (annual, 2022-12-31) — Inventory: 2068000000.00
HCA balance_sheet (annual, 2022-12-31) — Invested Capital: 35317000000.00
HCA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -3389000000.00
HCA balance_sheet (annual, 2022-12-31) — Investments And Advances: 1204000000.00
HCA balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 823000000.00
HCA balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 823000000.00
HCA balance_sheet (annual, 2022-12-31) — Investmentsin Subsidiariesat Cost: 381000000.00
HCA cash_flow (annual, 2022-12-31) — Issuance Of Debt: 6117000000.00
HCA balance_sheet (annual, 2022-12-31) — Land And Improvements: 2799000000.00
HCA balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1752000000.00
HCA balance_sheet (annual, 2022-12-31) — Long Term Debt: 37714000000.00
HCA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 39466000000.00
HCA cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 6117000000.00
HCA cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2830000000.00
HCA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 1204000000.00
HCA balance_sheet (annual, 2022-12-31) — Minority Interest: 2694000000.00
HCA income_statement (annual, 2022-12-31) — Minority Interests: -1191000000.00
HCA cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 1013000000.00
HCA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -7000000000.00
HCA balance_sheet (annual, 2022-12-31) — Net Debt: 37176000000.00
HCA income_statement (annual, 2022-12-31) — Net Income: 5643000000.00
HCA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 5643000000.00
HCA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6834000000.00
HCA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 5643000000.00
HCA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 5643000000.00
HCA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6834000000.00
HCA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6834000000.00
HCA income_statement (annual, 2022-12-31) — Net Interest Income: -1741000000.00
HCA cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 14000000.00
HCA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 3287000000.00
HCA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 3287000000.00
HCA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1741000000.00
HCA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1290000000.00
HCA cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -21000000.00
HCA balance_sheet (annual, 2022-12-31) — Net PPE: 27640000000.00
HCA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4395000000.00
HCA cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 120000000.00
HCA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -12420000000.00
HCA income_statement (annual, 2022-12-31) — Normalized EBITDA: 12067000000.00
HCA income_statement (annual, 2022-12-31) — Normalized Income: 4668269000.00
HCA cash_flow (annual, 2022-12-31) — Operating Cash Flow: 8522000000.00
HCA cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1223000000.00
HCA income_statement (annual, 2022-12-31) — Operating Income: 9053000000.00
HCA income_statement (annual, 2022-12-31) — Operating Revenue: 56719000000.00
HCA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 277378300.00
HCA balance_sheet (annual, 2022-12-31) — Other Current Assets: 1776000000.00
HCA balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 370000000.00
HCA balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -490000000.00
HCA income_statement (annual, 2022-12-31) — Other Income Expense: 1268000000.00
HCA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 182000000.00
HCA balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 298000000.00
HCA balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 3143000000.00
HCA income_statement (annual, 2022-12-31) — Other Operating Expenses: 11155000000.00
HCA balance_sheet (annual, 2022-12-31) — Other Properties: 32046000000.00
HCA income_statement (annual, 2022-12-31) — Other Special Charges: 78000000.00
HCA balance_sheet (annual, 2022-12-31) — Payables: 4610000000.00
HCA balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 8374000000.00
HCA balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 794000000.00
HCA income_statement (annual, 2022-12-31) — Pretax Income: 8580000000.00
HCA balance_sheet (annual, 2022-12-31) — Properties: 0.00
HCA cash_flow (annual, 2022-12-31) — Purchase Of Business: -224000000.00
HCA cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4395000000.00
HCA balance_sheet (annual, 2022-12-31) — Receivables: 8891000000.00
HCA income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 37056000000.00
HCA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2969000000.00
HCA cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2830000000.00
HCA cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -7000000000.00
HCA balance_sheet (annual, 2022-12-31) — Retained Earnings: -2280000000.00
HCA income_statement (annual, 2022-12-31) — Salaries And Wages: 27685000000.00
HCA cash_flow (annual, 2022-12-31) — Sale Of Business: 1237000000.00
HCA income_statement (annual, 2022-12-31) — Selling General And Administration: 27685000000.00
HCA balance_sheet (annual, 2022-12-31) — Share Issued: 277378300.00
HCA income_statement (annual, 2022-12-31) — Special Income Charges: 1223000000.00
HCA cash_flow (annual, 2022-12-31) — Stock Based Compensation: 341000000.00
HCA balance_sheet (annual, 2022-12-31) — Stockholders Equity: -2767000000.00
HCA balance_sheet (annual, 2022-12-31) — Tangible Book Value: -12420000000.00
HCA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 248269000.00
HCA income_statement (annual, 2022-12-31) — Tax Provision: 1746000000.00
HCA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.20
HCA balance_sheet (annual, 2022-12-31) — Total Assets: 52438000000.00
HCA balance_sheet (annual, 2022-12-31) — Total Capitalization: 34947000000.00
HCA balance_sheet (annual, 2022-12-31) — Total Debt: 40200000000.00
HCA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -73000000.00
HCA income_statement (annual, 2022-12-31) — Total Expenses: 51180000000.00
HCA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 52511000000.00
HCA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 38795000000.00
HCA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 42609000000.00
HCA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 371000000.00
HCA income_statement (annual, 2022-12-31) — Total Unusual Items: 1223000000.00
HCA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1223000000.00
HCA balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 1615000000.00
HCA balance_sheet (annual, 2022-12-31) — Working Capital: 3741000000.00
HCA income_statement (annual, 2023-12-31) — +Operating Expense: 15952000000.00
HCA income_statement (annual, 2023-12-31) — +Total Revenue: 64968000000.00
HCA balance_sheet (annual, 2023-12-31) — Accounts Payable: 4233000000.00
HCA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 9958000000.00
HCA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -30833000000.00
HCA income_statement (annual, 2023-12-31) — Basic Average Shares: 265537300.00
HCA income_statement (annual, 2023-12-31) — Basic EPS: 19.74
HCA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 908000000.00
HCA balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 21560000000.00
HCA cash_flow (annual, 2023-12-31) — Capital Expenditure: -4744000000.00
HCA balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2266000000.00
HCA balance_sheet (annual, 2023-12-31) — Capital Stock: 3000000.00
HCA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 935000000.00
HCA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 935000000.00
HCA cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -661000000.00
HCA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -4094000000.00
HCA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -5317000000.00
HCA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 9431000000.00
HCA cash_flow (annual, 2023-12-31) — Change In Inventory: -126000000.00
HCA cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 604000000.00
HCA cash_flow (annual, 2023-12-31) — Change In Receivables: -935000000.00
HCA cash_flow (annual, 2023-12-31) — Change In Working Capital: -457000000.00
HCA cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -935000000.00
HCA cash_flow (annual, 2023-12-31) — Changes In Cash: 20000000.00
HCA balance_sheet (annual, 2023-12-31) — Common Stock: 3000000.00
HCA cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -661000000.00
HCA balance_sheet (annual, 2023-12-31) — Common Stock Equity: -1774000000.00
HCA cash_flow (annual, 2023-12-31) — Common Stock Payments: -3811000000.00
HCA balance_sheet (annual, 2023-12-31) — Construction In Progress: 1870000000.00
HCA income_statement (annual, 2023-12-31) — Cost Of Revenue: 39389000000.00
HCA balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 4386000000.00
HCA balance_sheet (annual, 2023-12-31) — Current Assets: 14927000000.00
HCA balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 363000000.00
HCA balance_sheet (annual, 2023-12-31) — Current Debt: 2424000000.00
HCA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2787000000.00
HCA balance_sheet (annual, 2023-12-31) — Current Liabilities: 12655000000.00
HCA cash_flow (annual, 2023-12-31) — Deferred Income Tax: 229000000.00
HCA cash_flow (annual, 2023-12-31) — Deferred Tax: 229000000.00
HCA cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 3077000000.00
HCA income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 3077000000.00
HCA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 3077000000.00
HCA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 3077000000.00
HCA income_statement (annual, 2023-12-31) — Diluted Average Shares: 276412000.00
HCA income_statement (annual, 2023-12-31) — Diluted EPS: 18.97
HCA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 5242000000.00
HCA income_statement (annual, 2023-12-31) — EBIT: 9644000000.00
HCA income_statement (annual, 2023-12-31) — EBITDA: 12721000000.00
HCA income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 22000000.00
HCA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 7000000.00
HCA cash_flow (annual, 2023-12-31) — End Cash Position: 935000000.00
HCA cash_flow (annual, 2023-12-31) — Financing Cash Flow: -4094000000.00
HCA cash_flow (annual, 2023-12-31) — Free Cash Flow: 4687000000.00
HCA cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 5000000.00
HCA income_statement (annual, 2023-12-31) — Gain On Sale Of Business: -5000000.00
HCA balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -425000000.00
HCA income_statement (annual, 2023-12-31) — General And Administrative Expense: 29487000000.00
HCA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 9945000000.00
HCA balance_sheet (annual, 2023-12-31) — Gross PPE: 60755000000.00
HCA income_statement (annual, 2023-12-31) — Gross Profit: 25579000000.00
HCA cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1386000000.00
HCA income_statement (annual, 2023-12-31) — Interest Expense: 1938000000.00
HCA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1938000000.00
HCA cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1892000000.00
HCA balance_sheet (annual, 2023-12-31) — Interest Payable: 414000000.00
HCA balance_sheet (annual, 2023-12-31) — Inventory: 2021000000.00
HCA balance_sheet (annual, 2023-12-31) — Invested Capital: 37819000000.00
HCA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -5317000000.00
HCA balance_sheet (annual, 2023-12-31) — Investments And Advances: 1233000000.00
HCA balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 756000000.00
HCA balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 756000000.00
HCA balance_sheet (annual, 2023-12-31) — Investmentsin Subsidiariesat Cost: 477000000.00
HCA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 3224000000.00
HCA balance_sheet (annual, 2023-12-31) — Land And Improvements: 3120000000.00
HCA balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1903000000.00
HCA balance_sheet (annual, 2023-12-31) — Long Term Debt: 37169000000.00
HCA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 39072000000.00
HCA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 3224000000.00
HCA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -909000000.00
HCA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1233000000.00
HCA balance_sheet (annual, 2023-12-31) — Minority Interest: 2834000000.00
HCA income_statement (annual, 2023-12-31) — Minority Interests: -849000000.00
HCA cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -442000000.00
HCA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -3811000000.00
HCA balance_sheet (annual, 2023-12-31) — Net Debt: 38658000000.00
HCA income_statement (annual, 2023-12-31) — Net Income: 5242000000.00
HCA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 5242000000.00
HCA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 6091000000.00
HCA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 5242000000.00
HCA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 5242000000.00
HCA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 6091000000.00
HCA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 6091000000.00
HCA income_statement (annual, 2023-12-31) — Net Interest Income: -1938000000.00
HCA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -112000000.00
HCA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 1295000000.00
HCA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 2315000000.00
HCA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1938000000.00
HCA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -917000000.00
HCA cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -19000000.00
HCA balance_sheet (annual, 2023-12-31) — Net PPE: 29922000000.00
HCA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -4744000000.00
HCA cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -1020000000.00
HCA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -11719000000.00
HCA income_statement (annual, 2023-12-31) — Normalized EBITDA: 12726000000.00
HCA income_statement (annual, 2023-12-31) — Normalized Income: 5245950000.00
HCA cash_flow (annual, 2023-12-31) — Operating Cash Flow: 9431000000.00
HCA cash_flow (annual, 2023-12-31) — Operating Gains Losses: 5000000.00
HCA income_statement (annual, 2023-12-31) — Operating Income: 9627000000.00
HCA income_statement (annual, 2023-12-31) — Operating Revenue: 61894000000.00
HCA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 265537300.00
HCA balance_sheet (annual, 2023-12-31) — Other Current Assets: 2013000000.00
HCA balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2424000000.00
HCA balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -425000000.00
HCA income_statement (annual, 2023-12-31) — Other Income Expense: 17000000.00
HCA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 224000000.00
HCA balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 184000000.00
HCA balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 3424000000.00
HCA income_statement (annual, 2023-12-31) — Other Operating Expenses: 12875000000.00
HCA balance_sheet (annual, 2023-12-31) — Other Properties: 34205000000.00
HCA balance_sheet (annual, 2023-12-31) — Payables: 4615000000.00
HCA balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 9001000000.00
HCA balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 867000000.00
HCA income_statement (annual, 2023-12-31) — Pretax Income: 7706000000.00
HCA balance_sheet (annual, 2023-12-31) — Properties: 0.00
HCA cash_flow (annual, 2023-12-31) — Purchase Of Business: -635000000.00
HCA cash_flow (annual, 2023-12-31) — Purchase Of PPE: -4744000000.00
HCA balance_sheet (annual, 2023-12-31) — Receivables: 9958000000.00
HCA income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 39389000000.00
HCA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 3077000000.00
HCA cash_flow (annual, 2023-12-31) — Repayment Of Debt: -909000000.00
HCA cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -3811000000.00
HCA balance_sheet (annual, 2023-12-31) — Retained Earnings: -1352000000.00
HCA income_statement (annual, 2023-12-31) — Salaries And Wages: 29487000000.00
HCA cash_flow (annual, 2023-12-31) — Sale Of Business: 193000000.00
HCA income_statement (annual, 2023-12-31) — Selling General And Administration: 29487000000.00
HCA balance_sheet (annual, 2023-12-31) — Share Issued: 265537300.00
HCA income_statement (annual, 2023-12-31) — Special Income Charges: -5000000.00
HCA cash_flow (annual, 2023-12-31) — Stock Based Compensation: 262000000.00
HCA balance_sheet (annual, 2023-12-31) — Stockholders Equity: -1774000000.00
HCA balance_sheet (annual, 2023-12-31) — Tangible Book Value: -11719000000.00
HCA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1050000.00
HCA income_statement (annual, 2023-12-31) — Tax Provision: 1615000000.00
HCA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
HCA balance_sheet (annual, 2023-12-31) — Total Assets: 56211000000.00
HCA balance_sheet (annual, 2023-12-31) — Total Capitalization: 35395000000.00
HCA balance_sheet (annual, 2023-12-31) — Total Debt: 41859000000.00
HCA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1060000000.00
HCA income_statement (annual, 2023-12-31) — Total Expenses: 55341000000.00
HCA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 55151000000.00
HCA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 41284000000.00
HCA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 42496000000.00
HCA balance_sheet (annual, 2023-12-31) — Total Tax Payable: 382000000.00
HCA income_statement (annual, 2023-12-31) — Total Unusual Items: -5000000.00
HCA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -5000000.00
HCA balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 1867000000.00
HCA balance_sheet (annual, 2023-12-31) — Working Capital: 2272000000.00
HCA balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 0.00
HCA income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 7861000000.00
HCA income_statement (quarterly, 2024-09-30) — Salaries And Wages: 7861000000.00
HCA income_statement (quarterly, 2024-09-30) — Selling General And Administration: 7861000000.00
HCA income_statement (annual, 2024-12-31) — +Operating Expense: 18131000000.00
HCA income_statement (annual, 2024-12-31) — +Total Revenue: 70603000000.00
HCA balance_sheet (annual, 2024-12-31) — Accounts Payable: 4276000000.00
HCA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 10751000000.00
HCA balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -33100000000.00
HCA income_statement (annual, 2024-12-31) — Basic Average Shares: 249981400.00
HCA income_statement (annual, 2024-12-31) — Basic EPS: 23.04
HCA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 935000000.00
HCA balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 22691000000.00
HCA balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 22691000000.00
HCA cash_flow (annual, 2024-12-31) — Capital Expenditure: -4875000000.00
HCA balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2206000000.00
HCA balance_sheet (annual, 2024-12-31) — Capital Stock: 3000000.00
HCA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1933000000.00
HCA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1933000000.00
HCA cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -690000000.00
HCA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -4582000000.00
HCA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -4933000000.00
HCA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 10514000000.00
HCA cash_flow (annual, 2024-12-31) — Change In Inventory: 334000000.00
HCA cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 359000000.00
HCA cash_flow (annual, 2024-12-31) — Change In Receivables: -799000000.00
HCA cash_flow (annual, 2024-12-31) — Change In Working Capital: -106000000.00
HCA cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -799000000.00
HCA cash_flow (annual, 2024-12-31) — Changes In Cash: 999000000.00
HCA balance_sheet (annual, 2024-12-31) — Common Stock: 3000000.00
HCA cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -690000000.00
HCA balance_sheet (annual, 2024-12-31) — Common Stock Equity: -2499000000.00
HCA cash_flow (annual, 2024-12-31) — Common Stock Payments: -6042000000.00
HCA balance_sheet (annual, 2024-12-31) — Construction In Progress: 1858000000.00
HCA balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1858000000.00
HCA income_statement (annual, 2024-12-31) — Cost Of Revenue: 41925000000.00
HCA balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 4531000000.00
HCA balance_sheet (annual, 2024-12-31) — Current Assets: 16414000000.00
HCA balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 343000000.00
HCA balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 343000000.00
HCA balance_sheet (annual, 2024-12-31) — Current Debt: 4698000000.00
HCA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 5041000000.00
HCA balance_sheet (annual, 2024-12-31) — Current Liabilities: 15177000000.00
HCA cash_flow (annual, 2024-12-31) — Deferred Income Tax: 22000000.00
HCA cash_flow (annual, 2024-12-31) — Deferred Tax: 22000000.00
HCA cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 3312000000.00
HCA income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 3312000000.00
HCA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 3312000000.00
HCA income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 3312000000.00
HCA income_statement (annual, 2024-12-31) — Diluted Average Shares: 261806000.00
HCA income_statement (annual, 2024-12-31) — Diluted EPS: 22.00
HCA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 5760000000.00
HCA income_statement (annual, 2024-12-31) — EBIT: 10584000000.00
HCA income_statement (annual, 2024-12-31) — EBITDA: 13896000000.00
HCA income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 23000000.00
HCA cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1000000.00
HCA cash_flow (annual, 2024-12-31) — End Cash Position: 1933000000.00
HCA cash_flow (annual, 2024-12-31) — Financing Cash Flow: -4582000000.00
HCA cash_flow (annual, 2024-12-31) — Free Cash Flow: 5639000000.00
HCA cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -14000000.00
HCA income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 14000000.00
HCA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -387000000.00
HCA income_statement (annual, 2024-12-31) — General And Administrative Expense: 31170000000.00
HCA income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 7917000000.00
HCA balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 10093000000.00
HCA balance_sheet (annual, 2024-12-31) — Gross PPE: 64645000000.00
HCA income_statement (annual, 2024-12-31) — Gross Profit: 28678000000.00
HCA cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1844000000.00
HCA cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 358000000.00
HCA income_statement (annual, 2024-12-31) — Interest Expense: 2061000000.00
HCA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 2061000000.00
HCA cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1938000000.00
HCA balance_sheet (annual, 2024-12-31) — Interest Payable: 502000000.00
HCA balance_sheet (quarterly, 2024-12-31) — Interest Payable: 502000000.00
HCA balance_sheet (annual, 2024-12-31) — Inventory: 1738000000.00
HCA balance_sheet (annual, 2024-12-31) — Invested Capital: 40532000000.00
HCA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -4933000000.00
HCA balance_sheet (annual, 2024-12-31) — Investments And Advances: 1231000000.00
HCA balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 662000000.00
HCA balance_sheet (annual, 2024-12-31) — Investmentsin Subsidiariesat Cost: 569000000.00
HCA cash_flow (annual, 2024-12-31) — Issuance Of Debt: 7495000000.00
HCA balance_sheet (annual, 2024-12-31) — Land And Improvements: 3295000000.00
HCA balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 3295000000.00
HCA balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1863000000.00
HCA balance_sheet (annual, 2024-12-31) — Long Term Debt: 38333000000.00
HCA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 40196000000.00
HCA cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 7495000000.00
HCA cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2410000000.00
HCA balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 1231000000.00
HCA balance_sheet (annual, 2024-12-31) — Minority Interest: 3054000000.00
HCA income_statement (annual, 2024-12-31) — Minority Interests: -897000000.00
HCA cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 62000000.00
HCA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -6042000000.00
HCA balance_sheet (annual, 2024-12-31) — Net Debt: 41098000000.00
HCA income_statement (annual, 2024-12-31) — Net Income: 5760000000.00
HCA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 5760000000.00
HCA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 6657000000.00
HCA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 5760000000.00
HCA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 5760000000.00
HCA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 6657000000.00
HCA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 6657000000.00
HCA income_statement (annual, 2024-12-31) — Net Interest Income: -2061000000.00
HCA cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -115000000.00
HCA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 3205000000.00
HCA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 5085000000.00
HCA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -2061000000.00
HCA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1055000000.00
HCA cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -5000000.00
HCA balance_sheet (annual, 2024-12-31) — Net PPE: 31545000000.00
HCA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -4875000000.00
HCA cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -1880000000.00
HCA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -12592000000.00
HCA income_statement (annual, 2024-12-31) — Normalized EBITDA: 13882000000.00
HCA income_statement (annual, 2024-12-31) — Normalized Income: 5749066000.00
HCA cash_flow (annual, 2024-12-31) — Operating Cash Flow: 10514000000.00
HCA cash_flow (annual, 2024-12-31) — Operating Gains Losses: -14000000.00
HCA income_statement (annual, 2024-12-31) — Operating Income: 10547000000.00
HCA income_statement (annual, 2024-12-31) — Operating Revenue: 68061000000.00
HCA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 249981400.00
HCA balance_sheet (annual, 2024-12-31) — Other Current Assets: 1992000000.00
HCA balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 4698000000.00
HCA balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 4698000000.00
HCA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -387000000.00
HCA income_statement (annual, 2024-12-31) — Other Income Expense: 37000000.00
HCA cash_flow (annual, 2024-12-31) — Other Non Cash Items: 283000000.00
HCA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 230000000.00
HCA balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 3585000000.00
HCA income_statement (annual, 2024-12-31) — Other Operating Expenses: 14819000000.00
HCA balance_sheet (annual, 2024-12-31) — Other Properties: 36801000000.00
HCA balance_sheet (annual, 2024-12-31) — Payables: 4695000000.00
HCA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 9226000000.00
HCA balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 910000000.00
HCA balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 910000000.00
HCA income_statement (annual, 2024-12-31) — Pretax Income: 8523000000.00
HCA balance_sheet (annual, 2024-12-31) — Properties: 0.00
HCA balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
HCA cash_flow (annual, 2024-12-31) — Purchase Of Business: -266000000.00
HCA cash_flow (annual, 2024-12-31) — Purchase Of PPE: -4875000000.00
HCA balance_sheet (annual, 2024-12-31) — Receivables: 10751000000.00
HCA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 41925000000.00
HCA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3312000000.00
HCA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2410000000.00
HCA cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -6042000000.00
HCA balance_sheet (annual, 2024-12-31) — Retained Earnings: -2115000000.00
HCA income_statement (annual, 2024-12-31) — Salaries And Wages: 31170000000.00
HCA income_statement (quarterly, 2024-12-31) — Salaries And Wages: 7917000000.00
HCA cash_flow (annual, 2024-12-31) — Sale Of Business: 328000000.00
HCA income_statement (annual, 2024-12-31) — Selling General And Administration: 31170000000.00
HCA income_statement (quarterly, 2024-12-31) — Selling General And Administration: 7917000000.00
HCA balance_sheet (annual, 2024-12-31) — Share Issued: 249981400.00
HCA income_statement (annual, 2024-12-31) — Special Income Charges: 14000000.00
HCA cash_flow (annual, 2024-12-31) — Stock Based Compensation: 360000000.00
HCA balance_sheet (annual, 2024-12-31) — Stockholders Equity: -2499000000.00
HCA balance_sheet (annual, 2024-12-31) — Tangible Book Value: -12592000000.00
HCA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 3066000.00
HCA income_statement (annual, 2024-12-31) — Tax Provision: 1866000000.00
HCA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
HCA balance_sheet (annual, 2024-12-31) — Total Assets: 59513000000.00
HCA balance_sheet (annual, 2024-12-31) — Total Capitalization: 35834000000.00
HCA balance_sheet (annual, 2024-12-31) — Total Debt: 45237000000.00
HCA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 555000000.00
HCA income_statement (annual, 2024-12-31) — Total Expenses: 60056000000.00
HCA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 58958000000.00
HCA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 43099000000.00
HCA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 43781000000.00
HCA balance_sheet (annual, 2024-12-31) — Total Tax Payable: 419000000.00
HCA balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 419000000.00
HCA income_statement (annual, 2024-12-31) — Total Unusual Items: 14000000.00
HCA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 14000000.00
HCA balance_sheet (annual, 2024-12-31) — Working Capital: 1237000000.00
HCA income_statement (quarterly, 2025-03-31) — +Operating Expense: 4705000000.00
HCA income_statement (quarterly, 2025-03-31) — +Total Revenue: 18321000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4488000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 11088000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -33942000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 0.00
HCA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 242955400.00
HCA income_statement (quarterly, 2025-03-31) — Basic EPS: 6.63
HCA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1933000000.00
HCA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -991000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1860000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1060000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1060000000.00
HCA cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -180000000.00
HCA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1495000000.00
HCA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1032000000.00
HCA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1651000000.00
HCA cash_flow (quarterly, 2025-03-31) — Change In Inventory: -360000000.00
HCA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1000000000.00
HCA cash_flow (quarterly, 2025-03-31) — Change In Receivables: -327000000.00
HCA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1687000000.00
HCA cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -327000000.00
HCA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -876000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000000.00
HCA cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -180000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -3519000000.00
HCA cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -2506000000.00
HCA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 10761000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 5624000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Current Assets: 16258000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Current Debt: 3519000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3519000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 13631000000.00
HCA cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 492000000.00
HCA cash_flow (quarterly, 2025-03-31) — Deferred Tax: 492000000.00
HCA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 860000000.00
HCA income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 860000000.00
HCA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 860000000.00
HCA income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 860000000.00
HCA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 249440000.00
HCA income_statement (quarterly, 2025-03-31) — Diluted EPS: 6.45
HCA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1610000000.00
HCA income_statement (quarterly, 2025-03-31) — EBIT: 2874000000.00
HCA income_statement (quarterly, 2025-03-31) — EBITDA: 3734000000.00
HCA income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 18000000.00
HCA cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 3000000.00
HCA cash_flow (quarterly, 2025-03-31) — End Cash Position: 1060000000.00
HCA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1495000000.00
HCA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 660000000.00
HCA cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -1000000.00
HCA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 1000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -357000000.00
HCA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 7997000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 10237000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 65812000000.00
HCA income_statement (quarterly, 2025-03-31) — Gross Profit: 7560000000.00
HCA cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 10000000.00
HCA income_statement (quarterly, 2025-03-31) — Interest Expense: 547000000.00
HCA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 547000000.00
HCA cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 539000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Inventory: 1794000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 41057000000.00
HCA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1032000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1207000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 657000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Investmentsin Subsidiariesat Cost: 550000000.00
HCA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 5453000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1860000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 41057000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 42917000000.00
HCA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 5453000000.00
HCA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3895000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1207000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3081000000.00
HCA income_statement (quarterly, 2025-03-31) — Minority Interests: -215000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -66000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -2506000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Net Debt: 43516000000.00
HCA income_statement (quarterly, 2025-03-31) — Net Income: 1610000000.00
HCA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1610000000.00
HCA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1825000000.00
HCA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1610000000.00
HCA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1610000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1825000000.00
HCA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1825000000.00
HCA income_statement (quarterly, 2025-03-31) — Net Interest Income: -547000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 28000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 1558000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 1558000000.00
HCA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -547000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -367000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -3000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Net PPE: 31870000000.00
HCA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -991000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -13756000000.00
HCA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3733000000.00
HCA income_statement (quarterly, 2025-03-31) — Normalized Income: 1609216000.00
HCA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1651000000.00
HCA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1000000.00
HCA income_statement (quarterly, 2025-03-31) — Operating Income: 2855000000.00
HCA income_statement (quarterly, 2025-03-31) — Operating Revenue: 17749000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 242955400.00
HCA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2316000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -357000000.00
HCA income_statement (quarterly, 2025-03-31) — Other Income Expense: 19000000.00
HCA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 64000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 226000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 3688000000.00
HCA income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 3845000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Other Properties: 65812000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Payables: 4488000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 10112000000.00
HCA income_statement (quarterly, 2025-03-31) — Pretax Income: 2327000000.00
HCA cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -227000000.00
HCA cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -991000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Receivables: 11088000000.00
HCA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 10761000000.00
HCA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 860000000.00
HCA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3895000000.00
HCA cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -2506000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -3164000000.00
HCA income_statement (quarterly, 2025-03-31) — Salaries And Wages: 7997000000.00
HCA cash_flow (quarterly, 2025-03-31) — Sale Of Business: 161000000.00
HCA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 7997000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Share Issued: 242955400.00
HCA income_statement (quarterly, 2025-03-31) — Special Income Charges: 1000000.00
HCA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 98000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -3519000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -13756000000.00
HCA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 216000.00
HCA income_statement (quarterly, 2025-03-31) — Tax Provision: 502000000.00
HCA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
HCA balance_sheet (quarterly, 2025-03-31) — Total Assets: 59798000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 37538000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Total Debt: 46436000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -438000000.00
HCA income_statement (quarterly, 2025-03-31) — Total Expenses: 15466000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 60236000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 43540000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 46605000000.00
HCA income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1000000.00
HCA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1000000.00
HCA balance_sheet (quarterly, 2025-03-31) — Working Capital: 2627000000.00
HCA income_statement (quarterly, 2025-06-30) — +Operating Expense: 4656000000.00
HCA income_statement (quarterly, 2025-06-30) — +Total Revenue: 18605000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4250000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 10459000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -34265000000.00
HCA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 236143900.00
HCA income_statement (quarterly, 2025-06-30) — Basic EPS: 7.00
HCA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1060000000.00
HCA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1176000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1881000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 939000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 939000000.00
HCA cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -171000000.00
HCA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3089000000.00
HCA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1251000000.00
HCA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 4210000000.00
HCA cash_flow (quarterly, 2025-06-30) — Change In Inventory: -67000000.00
HCA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 324000000.00
HCA cash_flow (quarterly, 2025-06-30) — Change In Receivables: 647000000.00
HCA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 904000000.00